Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
KCNJ11新生儿糖尿病能否成功过渡到磺脲类药物治疗取决于基因突变类型和糖尿病病程。
期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-016-3921-8
Babiker, Tarig; Vedovato, Natascia; Patel, Kashyap; Thomas, Nicholas; Finn, Roisin; Männikkö, Roope; Chakera, Ali J; Flanagan, Sarah E; Shepherd, Maggie H; Ellard, Sian; Ashcroft, Frances M; Hattersley, Andrew T
